» Articles » PMID: 11591804

Unique T Cell Effector Functions Elicited by Plasmodium Falciparum Epitopes in Malaria-exposed Africans Tested by Three T Cell Assays

Overview
Journal J Immunol
Date 2001 Oct 10
PMID 11591804
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Natural immunity to malaria is characterized by low level CD4 T cell reactivity detected by either lymphoproliferation or IFN-gamma secretion. Here we show a doubling in the detection rate of responders to the carboxyl terminus of circumsporozoite protein (CS) of Plasmodium falciparum by employing three T cell assays simultaneously: rapid IFN-gamma secretion (ex vivo ELISPOT), IFN-gamma secretion after reactivation of memory T cells and expansion in vitro (cultured ELISPOT), and lymphoproliferation. Remarkably, for no individual peptide did a positive response for one T cell effector function correlate with any other. Thus these CS epitopes elicited unique T cell response patterns in malaria-exposed donors. Novel or important epitope responses may therefore be missed if only one T cell assay is employed. A borderline correlation was found between anti-CS Ab levels and proliferative responses, but no correlation was found with ex vivo or cultured IFN-gamma responses. This suggested that the proliferating population, but not the IFN-gamma-secreting cells, contained cells that provide help for Ab production. The data suggest that natural immunity to malaria is a complex function of T cell subgroups with different effector functions and has important implications for future studies of natural T cell immunity.

Citing Articles

Using two phases of the CD4 T cell response to blood-stage murine malaria to understand regulation of systemic immunity and placental pathology in Plasmodium falciparum infection.

Gbedande K, Carpio V, Stephens R Immunol Rev. 2020; 293(1):88-114.

PMID: 31903675 PMC: 7540220. DOI: 10.1111/imr.12835.


Comprehensive Review of Human -Specific CD8+ T Cell Epitopes.

Heide J, Vaughan K, Sette A, Jacobs T, Schulze Zur Wiesch J Front Immunol. 2019; 10:397.

PMID: 30949162 PMC: 6438266. DOI: 10.3389/fimmu.2019.00397.


Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine.

Moris P, Jongert E, van der Most R Hum Vaccin Immunother. 2017; 14(1):17-27.

PMID: 28934066 PMC: 5791571. DOI: 10.1080/21645515.2017.1381809.


Interferon- responses to vaccine candidate antigens decrease in the absence of malaria transmission.

Ayieko C, Ogola B, Ochola L, Ngwena G, Ayodo G, Hodges J PeerJ. 2017; 5:e2855.

PMID: 28097063 PMC: 5228499. DOI: 10.7717/peerj.2855.


Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.

Carapau D, Mitchell R, Nacer A, Shaw A, Othoro C, Frevert U Infect Immun. 2013; 81(12):4350-62.

PMID: 24042110 PMC: 3837993. DOI: 10.1128/IAI.00263-13.